| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibody response in children to antigen sites on human PIV-3 HN: correlation with known epitopes mapped by monoclonal antibodies
|
Henrickson, Kelly J.
|
|
1990
|
8 |
Supplement 1 |
p. 75-80
6 p.
|
artikel
|
| 2 |
Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine
|
Kantele, A.
|
|
1990
|
8 |
Supplement 1 |
p. 321-326
6 p.
|
artikel
|
| 3 |
Brucella suis S2, Brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice
|
Bosseray, Nicole
|
|
1990
|
8 |
Supplement 1 |
p. 462-468
7 p.
|
artikel
|
| 4 |
Characterization of the adjuvant-free serological response to protein antigens coupled to antibodies specific for class II MHC determinants
|
Carayanniotis, George
|
|
1990
|
8 |
Supplement 1 |
p. 137-144
8 p.
|
artikel
|
| 5 |
Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage
|
Poovorawan, Y.
|
|
1990
|
8 |
Supplement 1 |
p. S56-S59
4 p.
|
artikel
|
| 6 |
Comparison of immunogenicity of recombinant and plasma derived hepatitis B antigen in guinea-pigs
|
Valinger, Zdenka
|
|
1990
|
8 |
Supplement 1 |
p. 585-589
5 p.
|
artikel
|
| 7 |
Critical role of neighbouring sequences on the immunogenicity of the C3 poliovirus neutralization epitope expressed at the surface of recombinant bacteria
|
van der Werf, S.
|
|
1990
|
8 |
Supplement 1 |
p. 269-277
9 p.
|
artikel
|
| 8 |
Development and persistence of antibody in a high risk institutionalized population given plasma-derived hepatitis B vaccine
|
West, David J.
|
|
1990
|
8 |
Supplement 1 |
p. 111-114
4 p.
|
artikel
|
| 9 |
Effect of live attenuated, cold recombinant (CR) influenza virus vaccines on pulmonary function in healthy and asthmatic adults
|
Atmar, Robert L.
|
|
1990
|
8 |
Supplement 1 |
p. 217-224
8 p.
|
artikel
|
| 10 |
Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodialysis patients
|
Bruguera, M.
|
|
1990
|
8 |
Supplement 1 |
p. S47-S49
3 p.
|
artikel
|
| 11 |
Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3–6 months after immunization
|
Murphy, Brian R.
|
|
1990
|
8 |
Supplement 1 |
p. 497-502
6 p.
|
artikel
|
| 12 |
Enhancement of antibody responses to influenza B virus haemagglutinin by use of a new adjuvant formulation
|
Byars, Noelene E.
|
|
1990
|
8 |
Supplement 1 |
p. 49-56
8 p.
|
artikel
|
| 13 |
Epidemiology and erdication strategy for hepatitis B in Europe
|
Goudeau, A
|
|
1990
|
8 |
Supplement 1 |
p. S113-S116
4 p.
|
artikel
|
| 14 |
Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins
|
van Drunen Littel-van den Hurk, S.
|
|
1990
|
8 |
Supplement 1 |
p. 358-368
11 p.
|
artikel
|
| 15 |
Eradication strategies for HBV: Discussion, part 1
|
|
|
1990
|
8 |
Supplement 1 |
p. S93-S94
2 p.
|
artikel
|
| 16 |
Evaluation of a reassortant rhesus rotavirus vaccine in young children
|
Tajima, Takeshi
|
|
1990
|
8 |
Supplement 1 |
p. 70-74
5 p.
|
artikel
|
| 17 |
Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza
|
Tamura, Shin-ichi
|
|
1990
|
8 |
Supplement 1 |
p. 479-485
7 p.
|
artikel
|
| 18 |
Hepatitis B infection in sub-Saharan Africa
|
Kiire, C.F.
|
|
1990
|
8 |
Supplement 1 |
p. S107-S112
6 p.
|
artikel
|
| 19 |
Hepatitis B virus and primary hepatocellular carcinoma: treatment of HBV carriers with Phyllanthus amarus
|
Blumberg, B.S.
|
|
1990
|
8 |
Supplement 1 |
p. S86-S92
7 p.
|
artikel
|
| 20 |
Hepatitis B virus infection and health care workers
|
Hadler, S.C.
|
|
1990
|
8 |
Supplement 1 |
p. S24-S28
5 p.
|
artikel
|
| 21 |
Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndrome
|
Van Damme, P.
|
|
1990
|
8 |
Supplement 1 |
p. S53-S55
3 p.
|
artikel
|
| 22 |
Immunogenicity of glutaraldehyde inactivated pertussis vaccine
|
Gupta, Rajesh Kumar
|
|
1990
|
8 |
Supplement 1 |
p. 563-568
6 p.
|
artikel
|
| 23 |
Immunotherapeutic effects of a vaccine based on a saprophytic cultivable mycobacterium, Mycobacterium w in multibacillary leprosy patients
|
Talwar, G.P.
|
|
1990
|
8 |
Supplement 1 |
p. 121-129
9 p.
|
artikel
|
| 24 |
Isolated gA/gB glycoprotein complex of human cytomegalovirus envelope induces humoral and cellular immune-responses in human volunteers
|
Gonczol, Eva
|
|
1990
|
8 |
Supplement 1 |
p. 130-136
7 p.
|
artikel
|
| 25 |
Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers
|
Dentchev, V.
|
|
1990
|
8 |
Supplement 1 |
p. 30-34
5 p.
|
artikel
|
| 26 |
New retrovirus of the HIV virus group is useful in diagnosis of HIV-1 and HIV-2 infections and in AIDS vaccine production
|
|
|
1990
|
8 |
Supplement 1 |
p. 92-
1 p.
|
artikel
|
| 27 |
Persistence of antibodies after immunization with a recombinant yeast-derived hepatitis B vaccine following two different schedules
|
Scheiermann, N.
|
|
1990
|
8 |
Supplement 1 |
p. S44-S46
3 p.
|
artikel
|
| 28 |
Prophylactic activity of dihydro-heptaprenol, a synthetic polyprenol derivative, against Sendai virus infection in mice
|
Iida, Joji
|
|
1990
|
8 |
Supplement 1 |
p. 376-380
5 p.
|
artikel
|
| 29 |
Protection against lethal equine herpes virus type 1 (subtype 1) infection in hamsters by immune stimulating complexes (ISCOMs) containing the major viral glycoproteins
|
Cook, R.F.
|
|
1990
|
8 |
Supplement 1 |
p. 491-496
6 p.
|
artikel
|
| 30 |
Protective effect of inactivated Pasteurella haemolytica bacterin challenged in bovine herpesvirus-1 experimentally infected calves
|
Jericho, K.W.F.
|
|
1990
|
8 |
Supplement 1 |
p. 315-320
6 p.
|
artikel
|
| 31 |
Protective efficacy of a recombinant DNA vaccine against hepatitis B in male homosexuals: results at 36 months
|
Goilav, C.
|
|
1990
|
8 |
Supplement 1 |
p. S50-S52
3 p.
|
artikel
|
| 32 |
Purified chick-embryo-cell (PCEC) rabies vaccine: its potency performance in different test systems and in humans
|
Barth, R.
|
|
1990
|
8 |
Supplement 1 |
p. 41-48
8 p.
|
artikel
|
| 33 |
Risks of hepatitis B for travellers
|
Steffen, R.
|
|
1990
|
8 |
Supplement 1 |
p. S31-S32
2 p.
|
artikel
|
| 34 |
Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers
|
Wiedermann, G.
|
|
1990
|
8 |
Supplement 1 |
p. 581-584
4 p.
|
artikel
|
| 35 |
Serotype 1 reassortant of bovine rotavirus WC3, strain WI79-9, induces a polytypic antibody response in infants
|
Clark, H.F.
|
|
1990
|
8 |
Supplement 1 |
p. 327-332
6 p.
|
artikel
|
| 36 |
Vaccine for HIV virus type 1 is composed of a polypeptide devoid of any epitope of gp160 generating HIV virus infection-enhancing antibodies
|
|
|
1990
|
8 |
Supplement 1 |
p. 291-
1 p.
|
artikel
|
| 37 |
Vaccinia recombinants expressing early bovine papilloma virus (BPV1) proteins: retardation of BPV1 tumour development
|
Meneguzzi, Guerrino
|
|
1990
|
8 |
Supplement 1 |
p. 199-204
6 p.
|
artikel
|
| 38 |
Yeast-derived hepatitis B vaccine in dental students. A three-year follow-up study
|
Zanetti, A.R.
|
|
1990
|
8 |
Supplement 1 |
p. 205-208
4 p.
|
artikel
|
Tijdschrift beschrijving